Alzheimer's disease-related treatment - Future Science | Home

Those with baseline LDL-C levels 4.1-10.4 mmol/l were randomised to either Ezetrol (ezetimibe) 10 mg co-administered with simvastatin (10, 20 or 40 mg) or simvastatin (10, 20 or 40 mg) alone for 6 weeks, co-administered Ezetrol and 40 mg simvastatin or 40 mg simvastatin alone for the next 27 weeks and open-label coadministered Ezetrol and ... ................
................